Xianjin P. Zhu
China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Comparison of the clinical usefulness of CXCL-8 and conventional clinical tumor markers for gastric cancer diagnosis.
Journal: Clinics (Sao Paulo, Brazil)
Published: December 15, 2025
Overexpression and prognostic value of aspartate β-hydroxylase in lung adenocarcinoma: a comprehensive study based on bioinformatics and clinical tissue sample validation.
Journal: World journal of surgical oncology
Published: October 04, 2025
Oxaliplatin upregulates Cyr61 expression by inhibiting the Hippo-YAP pathway which contributes to drug resistance of colorectal cancer cells.
Journal: Discover oncology
Published: March 07, 2025
Clinical Significance and Potential Function of Complement Factor D in Acute Myeloid Leukemia.
Journal: Cureus
Published: August 20, 2024
Hypoxia-initiated Cysteine-rich protein 61 secretion promotes chemoresistance of acute B lymphoblastic leukemia cells.
Journal: American journal of cancer research
Published: March 07, 2024
Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity.
Journal: Journal of cancer research and clinical oncology
Published: October 24, 2023
Serum CYR61 as a potential biomarker to improve breast cancer diagnostics.
Journal: Biomarkers in medicine
Published: January 06, 2023
Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
Journal: BioMed research international
Published: March 02, 2022
Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients.
Journal: Clinical laboratory
Published: September 20, 2021
Last Updated: 09/26/2026